The REMBRANDT data portal provides researchers with access to data characterizing human brain neoplasias, including astrocytoma, GBM, oligodendroglioma, and other less-well-defined types (mixed, unknown, unclassified) as well as normal controls. The portal contains subject-annotation data focusing on survival for 668 subjects and two sets of microarray-based data sets, the first with copy-number data mapped to 241 subjects and the second with gene-expression data mapped to 579 subjects. A joint initiative of NCI and the National Institute of Neurological Disorders and Stroke (NINDS), REMBRANDT is a project of the NCI Division of Cancer Treatment and Diagnosis (DCTD) Cancer Diagnosis Program.

Go to "public studies" menu at the top right, and select "REMBRANDT" from the drop down options